Sprout Pharma adds $2.9M to funding round, now nearly $28M
Raleigh startup Sprout Pharmaceuticals continues to raise capital – the latest raise of $2.9 million from six more investors puts the total near $28 million.
Read More
sprout2
Raleigh’s Sprout Pharma’s funding round surpasses $25M raised with 85 investors so far
Sprout2, the business entity connected to Sprout Pharma, disclosed it has raised more than $25 million in an amended SEC filing this week.
Read MoreValeant, with connections to Raleigh, will change name to Bausch Health
Valeant, the company whose enormous price increases on old drugs helped fuel public outrage over high drug costs and also bought then sold Raleigh-based Sprout Pharmaceuticals, is changing its name.
Read MoreSprout2: Reborn Sprout Pharmaceuticals draws 203 investors in $4.5M deal
Sprout Pharmaceuticals is getting back into business as Sprout2 with 203 investors lining up to launch the company that was sold just two years ago to Valeant Pharmaceuticals for $1 billion
Read More
